"ventilación mecánica" in English

No infant in any trial required intubation and mechanical ventilation.

A new lung-protective way of mechanical ventilation was tested in large trials.

For severe RDS, surfactant administration during mechanical ventilation is used.

Patients with this syndrome require mechanical ventilation.

To determine the effects of inhaled beta2-agonists on asthmatic patients who require intubation and mechanical ventilation.

Noninvasive positive pressure ventilation (NPPV) provides ventilatory support without the need for an invasive airway approach.

However, current surfactant administration strategies require endotracheal intubation with or without continued mechanical ventilation.

The usual treatment includes instilling artificial surfactant directly into the newborn infant's airway followed by mechanical ventilation.

Bronchopulmonary dysplasia and chronic lung disease (CLD) are associated with mechanical ventilation and potentially life-long effects.

Critically ill patients affected by severe acute respiratory failure need air to be pumped into their lungs (mechanical ventilation) to survive.

Administration of inhalable prostacyclins requires continuous aerosols over a period of hours to several days, usually during mechanical ventilation.

This has the potential to reduce the need to support the infant's breathing after birth, as well as lung damage caused by mechanical ventilation.

In trials using animal derived surfactant in babies with RDS, multiple dose treatment lowered the risk of lung complications and there was a trend towards lowering the risk of death as well.

Invasive mechanical ventilation is undoubtedly a lifesaving procedure for patients with severe life threatening (respiratory failure) exacerbation of their COPD.